logo/base Created with Sketch.

FibroScan Q®

The integrated & mobile non-invasive solution for efficient liver disease management.

Powered by LSM by VCTE™ and CAP™ for liver fibrosis and liver steatosis assessment.

wave

FibroScan Q®  is designed for hospitals and clinics with featured light caster for rotate working in various departments, and with embedded battery for supporting bedside examination.

Ergonomic design

LSM by VCTE™ is unique, patented and validated for liver fibrosis assessment. It is the standard for non-invasive evaluation of liver stiffness with 2,250 international peer-reviewed publications.1

CAP™ is unique patented and validated for liver steatosis assessment2,3 with 330 international peer-reviewed publications.

What our users say

quote

The ability FibroScan® gives to painlessly and quickly locate a liver health risk to a person, which also is one of the world’s biggest silent killers is a no brainer. I have yet to have any person tell me they didn’t want to know, in fact the complete opposite almost everyone alters something in their lives to improve their own and families liver health. 

Louise Campbell | Founder and Medical Director Tawazun Health

chevron chevron

Products in the FibroScan® range are Class IIa medical devices as defined by Directive 93/42/EEC (EC 0459). These devices are designed for use in a medical practice in order to measure liver stiffness and ultrasound attenuation in patients with liver disease. Examinations with FibroScan® device shall be performed by an operator who has been certified by the manufacturer or its approved local representative. Operators are expressly recommended to carefully read the instructions given in the user manual and on the labelling of these products. Check cost defrayal conditions with paying bodies.

References are available in our bibliography.